About
Activity
7K followers
-
David Schur reposted thisDavid Schur reposted thisPreparing for the 340B Rebate Model is one thing. Operationalizing it is another. As #pharma manufacturers evaluate their approach, access to data and actionable insights will be critical for managing compliance, improving operational efficiency, and staying ahead of potential issues. In this video, Meghal Patel discusses the role technology can play in helping manufacturers transform data into actionable intelligence and take a more proactive approach to 340B rebate management. #ModelN #LifeSciences #340B
-
David Schur reposted thisDavid Schur reposted thisOn July 31, HRSA announced a revised 340B Rebate Model Pilot Program. So what should pharmaceutical manufacturers be doing right now to prepare? In this video, Jesse Mendelsohn shares his perspective on the steps manufacturers should be taking today. As organizations evaluate participation, they should also be assessing the operational, policy, and technology requirements needed to support participation. With the August 24 submission deadline approaching, now is the time to evaluate your operating model and technology strategy. Model N is helping manufacturers prepare for the August 24 deadline and implementation as the pilot rolls out in January 2027 and beyond. Interested in learning more? Contact your #ModelN representative or send us a direct message. #Pharma #LifeSciences #340B
-
David Schur reposted thisDavid Schur reposted this🚨 On July 31, HRSA announced a revised 340B Rebate Model Pilot Program, a significant and welcome step toward modernizing the 340B program. What does this mean? ✅ Improved sustainability of 340B while helping ensure resources reach patients and communities who need them most ✅ Greater transparency and accountability across the 340B ecosystem ✅ Stronger program integrity ✅ Increased need for trusted data and purpose-built technology ✅ A new level of readiness for participating manufacturers Model N's Truzo platform was purpose-built for 340B rebates. Designed to simplify participation for manufacturers, covered entities, and providers, Truzo delivers a secure, end-to-end platform that brings trusted data, transparency, and efficiency to every stage of the rebate process. Available today, Truzo enables manufacturers to prepare for January 1, 2027 with confidence. This announcement marks an important milestone for the industry, and we look forward to partnering with customers and stakeholders as the 340B landscape evolves. To our #pharma customers eligible for the pilot program, we'll be reaching out directly. If you'd like to continue the conversation, send us a direct message. Learn more about the pilot program: https://lnkd.in/g86anWbx #340B #Pharma #LifeSciencesHRSA Announces Revised 340B Rebate Model Pilot Program to Strengthen Care in Rural and Medically Underserved CommunitiesHRSA Announces Revised 340B Rebate Model Pilot Program to Strengthen Care in Rural and Medically Underserved Communities
-
David Schur reposted thisDavid Schur reposted this🚨 On July 31, HRSA announced a revised 340B Rebate Model Pilot Program, a significant and welcome step toward modernizing the 340B program. What does this mean? ✅ Improved sustainability of 340B while helping ensure resources reach patients and communities who need them most ✅ Greater transparency and accountability across the 340B ecosystem ✅ Stronger program integrity ✅ Increased need for trusted data and purpose-built technology ✅ A new level of readiness for participating manufacturers Model N's Truzo platform was purpose-built for 340B rebates. Designed to simplify participation for manufacturers, covered entities, and providers, Truzo delivers a secure, end-to-end platform that brings trusted data, transparency, and efficiency to every stage of the rebate process. Available today, Truzo enables manufacturers to prepare for January 1, 2027 with confidence. This announcement marks an important milestone for the industry, and we look forward to partnering with customers and stakeholders as the 340B landscape evolves. To our #pharma customers eligible for the pilot program, we'll be reaching out directly. If you'd like to continue the conversation, send us a direct message. Learn more about the pilot program: https://lnkd.in/g86anWbx #340B #Pharma #LifeSciencesHRSA Announces Revised 340B Rebate Model Pilot Program to Strengthen Care in Rural and Medically Underserved CommunitiesHRSA Announces Revised 340B Rebate Model Pilot Program to Strengthen Care in Rural and Medically Underserved Communities
-
David Schur shared thisExciting changes continue at Model N! Our High-Tech business is phenomenally positioned for even more growth with Vendavo and they will be welcoming many great team members.David Schur shared thisWe’re excited to share that Vendavo has signed an agreement to acquire Model N’s High-Tech business unit, subject to closing. 🎉 This is a big step forward in strengthening our leadership in semiconductor and high-tech manufacturing—and delivering even more value to customers. 𝗪𝗵𝗮𝘁 𝘁𝗵𝗶𝘀 𝗺𝗲𝗮𝗻𝘀 𝗳𝗼𝗿 𝗰𝘂𝘀𝘁𝗼𝗺𝗲𝗿𝘀: • A unified platform across pricing, rebates, quoting, and channel management • Greater visibility into margin and performance drivers • More connected, data-driven decision-making powered by AI • Continued investment in high-tech and semiconductor solutions • Stability today, with a clear path toward future innovation By bringing together our complementary strengths, we’re helping organizations better manage complexity and turn it into a competitive advantage. Learn more: https://lnkd.in/gr3hFVvW #Vendavo #HighTech #Semiconductor #RevenueManagement #SeizeYourEdge
-
David Schur shared thisSo very excited to join forces with Kalderos - a world class team that has created the industry leading platform - Truzo - for gross-to-net and the top solution for managing 340b programs. Model N + Kalderos will be a powerful combo. Excited about what we will build soon!David Schur shared this#ModelN announced it has acquired Kalderos, a technology company that provides a gross-to-net (GTN) intelligence platform with rich capabilities for driving visibility into 340B drug discount programs. “Model N delivers the commercial platform life sciences leaders rely on to expand market access, optimize revenue, and maintain compliance,” said Bret Connor, CEO of Model N. “Through Kalderos, we are providing a more proactive and precise way to manage complex drug pricing programs through a single, fully integrated revenue management solution. This is critical as pricing programs, rebate requirements, and 340B data demands become more complex.” Learn more: https://lnkd.in/grNjtz2w
-
David Schur reposted thisDavid Schur reposted this[Breaking News] Model N announced the appointment of Thomas Gibbs to the company’s board of directors. “Tom brings deep pharmaceutical leadership and extensive experience scaling complex, global organizations while driving measurable business impact,” said Bret Connor, CEO of Model N. “His strength lies in integrating strategy, analytics, and cross-functional collaboration to help drive sustainable growth. As Model N continues to advance its offerings and expand globally, we believe his expertise will play an important role in our continued momentum.” Read more: https://lnkd.in/ezAwXxEV
-
David Schur reposted thisDavid Schur reposted thisThat’s a wrap on Rainmaker 2026! Thank you to everyone who joined us throughout the week and helped make #MNRainmaker26 such a meaningful experience. We’re grateful for the conversations, connections, and insights that will carry forward well beyond the event. We’re heading to Music City next year. Save the date! 📍 Nashville, TN 📅 March 1–3, 2027 #Pharma #MedTech #HighTech #ModelN
-
David Schur reposted thisDavid Schur reposted thisToday at Rainmaker, Dan Koellhofer took the stage during the Product and Technology keynote to highlight #ModelN’s innovation roadmap, our commitment to customer success, and the technology trends shaping what’s next across our industries. Thanks to all who joined us! #MNRainmaker26 #LifeSciences #Pharma #MedTech #HighTech
-
David Schur liked thisI could not be more grateful for the time I got to spend with the amazing people at Team Applied! Together, we accomplished inspiring things and I am proud of the mark we left together on one of the world's most important industries. I am thrilled to hand the baton to Graham Blackwell - a uniquely talented leader who is the perfect fit for the bold vision and high ambitions that lay ahead for Team Applied. To all of my teammates, THANK YOU for an amazing journey! I am and always will be your biggest fan. Keep on climbing!David Schur liked thisToday we’re celebrating an incredible chapter in Applied Systems’ story. After seven years of visionary leadership, Taylor Rhodes is transitioning out of his role as CEO – leaving behind a legacy of growth, innovation, and an unwavering commitment to our people and our industry. During Taylor’s tenure, we expanded into new markets, launched key products, and grew our team. His impact on this company, and on all of us, will be felt for years to come. As we thank Taylor for everything he’s built, please join us in congratulating Graham Blackwell as he formally takes on the role of CEO. We have full confidence in his ability to lead Applied forward. Thank you, Taylor, for your steady hand, your vision, and your heart. And we couldn’t be more excited for what’s ahead with Graham. 🎉
-
David Schur liked thisDavid Schur liked thisStarting a new role at Model N? Bala Sigamani, Principal Solutions Architect at #ModelN, shares a few pieces of advice: stay curious, stay focused, and bring energy to everything you do. Thanks for sharing, Bala, and welcome to our newest team members! #ModelNLife #NFactor #ModelN
-
David Schur liked thisDavid Schur liked thisPreparing for the 340B Rebate Model is one thing. Operationalizing it is another. As #pharma manufacturers evaluate their approach, access to data and actionable insights will be critical for managing compliance, improving operational efficiency, and staying ahead of potential issues. In this video, Meghal Patel discusses the role technology can play in helping manufacturers transform data into actionable intelligence and take a more proactive approach to 340B rebate management. #ModelN #LifeSciences #340B
-
David Schur liked thisDavid Schur liked thisOn July 31, HRSA announced a revised 340B Rebate Model Pilot Program. So what should pharmaceutical manufacturers be doing right now to prepare? In this video, Jesse Mendelsohn shares his perspective on the steps manufacturers should be taking today. As organizations evaluate participation, they should also be assessing the operational, policy, and technology requirements needed to support participation. With the August 24 submission deadline approaching, now is the time to evaluate your operating model and technology strategy. Model N is helping manufacturers prepare for the August 24 deadline and implementation as the pilot rolls out in January 2027 and beyond. Interested in learning more? Contact your #ModelN representative or send us a direct message. #Pharma #LifeSciences #340B
-
David Schur liked thisDavid Schur liked this🚨 On July 31, HRSA announced a revised 340B Rebate Model Pilot Program, a significant and welcome step toward modernizing the 340B program. What does this mean? ✅ Improved sustainability of 340B while helping ensure resources reach patients and communities who need them most ✅ Greater transparency and accountability across the 340B ecosystem ✅ Stronger program integrity ✅ Increased need for trusted data and purpose-built technology ✅ A new level of readiness for participating manufacturers Model N's Truzo platform was purpose-built for 340B rebates. Designed to simplify participation for manufacturers, covered entities, and providers, Truzo delivers a secure, end-to-end platform that brings trusted data, transparency, and efficiency to every stage of the rebate process. Available today, Truzo enables manufacturers to prepare for January 1, 2027 with confidence. This announcement marks an important milestone for the industry, and we look forward to partnering with customers and stakeholders as the 340B landscape evolves. To our #pharma customers eligible for the pilot program, we'll be reaching out directly. If you'd like to continue the conversation, send us a direct message. Learn more about the pilot program: https://lnkd.in/g86anWbx #340B #Pharma #LifeSciencesHRSA Announces Revised 340B Rebate Model Pilot Program to Strengthen Care in Rural and Medically Underserved CommunitiesHRSA Announces Revised 340B Rebate Model Pilot Program to Strengthen Care in Rural and Medically Underserved Communities
-
David Schur liked thisDavid Schur liked thisThis week I was honored to have the opportunity to celebrate the multi-decade CCCIS careers of these two Legends (Phil Vertucci & George Rosch). It also serves as a great reminder of how quickly things can change. Put your family and put yourself first!
Experience & Education
Publications
-
The Best Practices for Managing Risk with Agile Software Development
Built In Chicago
See publicationI sat down with Built In Chicago and discussed how I mitigate risks with Agile software development.
Recommendations received
62 people have recommended David
Join now to viewOther similar profiles
Explore more posts
-
Kenny Ogunlowo
🏥 Build Gemini Enterprise Care Pathway Orchestration with a FHIR-native Agentic Architecture The interesting engineering problem is not making an agent answer clinical questions. It is safely coordinating intake → triage → diagnostics → care planning → follow-up across healthcare systems. A practical architecture: Patient/Provider → Gemini Enterprise Agents → Agent Router → Vertex AI Search/RAG → FHIR-native MCP Tools → Healthcare API → Clinical Workflow Engine → GKE 🤖Use specialized agents for intake, triage, diagnostics, care coordination, and follow-up, with deterministic policy enforcement between the agent and every clinical tool. Implementation 🔹 Agent Builder for agent orchestration and enterprise workflows 🔹Vertex AI Search for governed clinical knowledge retrieval 🔹Healthcare API / FHIR for interoperable clinical data 🔹MCP tools for controlled FHIR/API operations 🔹GKE + Terraform for reproducible workflow infrastructure ��� IAM, least privilege, audit logging and policy gates for security 🔹Human approval for high-impact clinical decisions and actions The agent should retrieve → reason → request action → validate → document → escalate, not directly control clinical systems without policy enforcement. The business value is operational: reduce coordination friction, improve information availability, automate administrative workflows, and create traceable care pathways while keeping clinical authority with appropriate humans and controls. The key architecture question: how much autonomy should a healthcare agent have before every action requires an explicit policy or human approval? #GeminiEnterprise #AgenticAI #HealthcareAI #FHIR #VertexAI #GKE #AISecurity #AIArchitecture
-
Gary Rikard
Such an exciting year ahead. Healthcare AI is finally crossing from digitization to cognition shifting value from administrative drag to clinical and scientific productivity, with revenue cycle intelligence as the first scalable proof of ROI. Today, administrative functions consume roughly one-quarter of total U.S. healthcare spending making AI-driven cognitive automation one of the few levers capable of reallocating dollars back to care, not just cutting costs. With average hospital operating margins near 2%, even a 30–50 basis-point improvement from AI-driven clinical intelligence can translate into a 15–25% relative margin uplift without adding beds, clinicians, or capital spend. #MBA #Healthcare #AI
-
Jane White
Our VP of Go-to-Market Strategies, Sudhir Kshirsagar, put together this 1-minute recap video of his amazing experience at the 2025 #MGMA Leaders Conference. It includes some highlights from the educational session he shared with MGMA's Mike Gracz entitled, "Maximizing Financial Success in Healthcare: A Data-Driven Case Study Approach." Want a copy of the slides? Respond back to this post or email us at info@whitespacehealth.com and we will send them to you. #DataDive #MGMAAnalytics #RevenueCycleAnalytics #OperationalAnalytics
Explore top content on LinkedIn
Find curated posts and insights for relevant topics all in one place.
View top content